Health
Researchers identify biomarkers that predict patient’s response to metformin treatment – News-Medical.net
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
Reviewed by Emily Henderson, B.Sc.Sep 18 2020
Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating.
Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient will respond to metformin treatment via a simple blood test.
Our study constitutes…
-
Noosa News23 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News22 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News21 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales